Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2025-12-24 @ 10:58 PM
NCT ID:
NCT00820469
Eligibility Criteria:
Inclusion Criteria:
* Patient who should be treated by rituximab for various autoimmune diseases or humoral acute rejection of renal transplant
* Patient older than 18 years old
* Patient who have signed the written informed consent form
Exclusion Criteria:
* Patient presenting a contra indication to rituximab (hypersensitivity, active infection, severe cardiac failure (NYHA class IV))
* Blood sampling impossibility
* Pregnant or breasting women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00820469
Study Brief:
Protocol Section:
NCT00820469